<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Aiming to find new <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> markers for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>), we applied proteomic methodologies to compare the soluble sub-proteome of healthy and tumoral colorectal mucosa </plain></SENT>
<SENT sid="1" pm="."><plain>Out of 91 differentially expressed proteins, 23 were selected by principal component analysis (<z:chebi fb="20" ids="36751">PCA</z:chebi>) as the major contributors to the overall difference detected </plain></SENT>
<SENT sid="2" pm="."><plain>After MS/MS analysis, 16 proteins were identified </plain></SENT>
<SENT sid="3" pm="."><plain>From those, we chose 14-3-3-zeta/delta, <z:hpo ids='HP_0009919'>retinoblastoma</z:hpo>-binding protein 4 (RBBP-4), DJ-1, and <z:chebi fb="0" ids="16862">nucleoside diphosphate</z:chebi> kinase A (NDK A) for further studies, on the basis of their levels and known implication in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Specific immunodetection demonstrated only the NDK A levels allowed to differentiate healthy mucosa from <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> tissue in <z:hpo ids='HP_0000001'>all</z:hpo> the patients </plain></SENT>
<SENT sid="5" pm="."><plain>Hence, we used the <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cell line Caco-2 to study the relationship between NDK A and colon cell <z:mp ids='MP_0002006'>tumorigenesis</z:mp>, finding it over-expressed in undifferentiated (<z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-like) cells regarding the differentiated ones </plain></SENT>
<SENT sid="6" pm="."><plain>Noticeably, we also found increased levels of the NDK A in the secretome of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-like cells and, as expected, indications of higher levels of NDK A in the serum of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients </plain></SENT>
<SENT sid="7" pm="."><plain>In conclusion, the four validated proteins could constitute a panel of tissue markers for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>, being the NDK A the most interesting candidate for further serum biomarker studies </plain></SENT>
</text></document>